Quent Capital’s Novartis NVS Stock Holding History

Quent Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.9K	Buy	44 +8	+22%	+$1.2K	﹤0.01%	1315
2026 Q1	$5.5K	Hold	36	–	–	﹤0.01%	1260
2025 Q4	$4.96K	Hold	36	–	–	﹤0.01%	1276
2025 Q3	$4.62K	Buy	+36	New	+$4.39K	﹤0.01%	1161
2025 Q2	–	Sell	-36	Closed	-$4.01K	–	931
2025 Q1	$4.01K	Sell	36 -90	-71%	-$9.58K	﹤0.01%	1051
2024 Q4	$12.3K	Hold	126	–	–	﹤0.01%	895
2024 Q3	$14.5K	Hold	126	–	–	﹤0.01%	945
2024 Q2	$13.4K	Hold	126	–	–	﹤0.01%	939
2024 Q1	$12.2K	Hold	126	–	–	﹤0.01%	979
2023 Q4	$12.7K	Hold	126	–	–	﹤0.01%	929
2023 Q3	$12.8K	Hold	126	–	–	﹤0.01%	882
2023 Q2	$12.7K	Hold	126	–	–	﹤0.01%	887
2023 Q1	$11.6K	Sell	126 -5	-4%	-$437	﹤0.01%	895
2022 Q4	$11.9K	Hold	131	–	–	﹤0.01%	864
2022 Q3	$10K	Buy	131 +50	+62%	+$4.14K	﹤0.01%	864
2022 Q2	$7K	Sell	81 -480	-86%	-$42.1K	﹤0.01%	898
2022 Q1	$49K	Hold	561	–	–	0.01%	600
2021 Q4	$49K	Buy	+561	New	+$46.6K	0.01%	549

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Quent Capital's NVS Position: Q2 2026 in Review

Quent Capital increased its Novartis (NVS) stake by 22% in Q2 2026, buying an estimated $1.2K and bringing the position to 44 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Quent Capital first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $49K in Q1 2022. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Quent Capital held 44 shares of Novartis worth $6.9K as of Q2 2026.
Quent Capital bought 8 Novartis shares in Q2 2026, an estimated $1.2K.
Novartis made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1315 holding.
Quent Capital first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
Quent Capital's Novartis position peaked at $49K in Q1 2022.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.